Publications

  • How to Make Your Drug Launch A Success

    October 23, 2017 | IN VIVO

    The pain is becoming all too common for many pharmaceutical executives. After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations.

  • How to Make Your Drug Launch a Success

    September 06, 2017 | Pharmaceuticals | Bain Brief

    Bain research shows successful pharmaceutical companies are overhauling their approach to drug launch—and they do three things right.

  • Bayer’s Euphoria Around New Cancer Medicine Meets Skepticism

    October 18, 2016 | Healthcare | Bloomberg | Media mention

    Large pharmaceutical companies are feeling the pressure from competition with newer pharma companies, particularly in the experimental drug pipelines. These newcomers are gaining footholds in these verticals by building market share in one or two types of tumors or focusing on a technology that can

  • Front Line of Healthcare Report 2016: The Shifting European Healthcare Landscape By the Numbers

    September 28, 2016 | Bain report

    For those providing services on the front line of healthcare in Europe, change is accelerating—and there’s no turning back. Digital technologies, cost pressure and tighter protocols are transforming care delivery.

  • Bain: private equity firms circling speciality pharma

    March 15, 2016 | Private Equity | Private Healthcare Investor | Media mention

    Bain & Company Partner Christian Mazzi believes the specialty generic pharmaceutical space is now one of the hottest "here and now" themes for private equity firms. Mazzi, who leads Bain's London Healthcare practice, told Private Healthcare Investor that specialist generic firms have traditionally

  • European private equity hones its skills in pharmaceuticals and medtech

    July 16, 2015 | Healthcare | Private Healthcare Investor | Media mention

    , the leader of Bain & Company's UK Healthcare practice, discusses the changing private equity appetite for pharmaceuticals and medical technology in Europe.

  • £5.8bn of NHS work being advertised to private sector

    July 29, 2014 | Financial Times | Media mention

    Christian Mazzi, sector head for Bain London’s healthcare practice was quoted in a recent FT article detailing an anticipated £5bn in NHS work being tendered to the private sector. Christian describes the situation as an ‘arms race’ as companies compete for the first-mover advantage.

  • ‘Arms race’ over £5bn NHS contracts

    July 29, 2013 | Healthcare | Financial Times | Media mention

    Private sector companies are engaged in an “arms race” to win £5bn of National Health Service work being tendered including hospitals, mental healthcare, pathology and GP clinics in a move that could transform the future of healthcare in Britain.

  • A new pharma launch paradigm: From one size fits all to a tailored product approach

    June 05, 2013 | Healthcare | Bain Brief

    Market access restrictions and fragmented pipelines are creating challenges for pharmaceutical companies trying to introduce new products. Successful pharmaceutical companies are tailoring their launches to one of four product archetypes and retooling their organizations into Launch Factories

  • Private equity and investors: Where is this relationship going?

    May 02, 2013 | Private Equity | Forbes.com

    The harsher realities of raising new funds and the downward pressure on returns have given both general partners and limited partners powerful incentives to try new things. The search is bringing forth intriguing variations in the PE business model.